Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luc Cabel

Showing results (61-70 of 78) with videos related to

Pageof 8
Sort By:
Breast (Edinburgh, Scotland)|February 9, 2021
Outcome beyond third-line chemotherapy for metastatic triple-negative breast cancer in the French ESME programLuc Cabel, Matthieu Carton, Barbara Pistilli, et al.
Cells|May 31, 2019
Circulating Tumor Cells and Circulating Tumor DNA Detection in Potentially Resectable Metastatic Colorectal Cancer: A Prospective Ancillary Study to the Unicancer Prodige-14 TrialFrançois-Clément Bidard, Nicolas Kiavue, Marc Ychou, et al.
Breast Cancer Research and Treatment|October 26, 2018
Oral etoposide in heavily pre-treated metastatic breast cancer: results from the ESME cohort and comparison with other chemotherapy regimensLuc Cabel, Matthieu Carton, Bianca Cheaib, et al.
NPJ Breast Cancer|January 29, 2026
Monitoring of circulating tumor DNA in patients with stage II-III breast cancer treated with neoadjuvant chemotherapyLuc Cabel, Julia Ah-Reum An, Hong-Kyu Kim, et al.
Breast (Edinburgh, Scotland)|August 9, 2022
Efficacy of taxanes rechallenge in first-line treatment of early metastatic relapse of patients with HER2-negative breast cancer previously treated with a (neo)adjuvant taxanes regimen: A multicentre retrospective observational studyAntoine Vasseur, Matthieu Carton, Severine Guiu, et al.
Breast Cancer Research : BCR|January 20, 2021
Characteristics and outcome of breast cancer-related microangiopathic haemolytic anaemia: a multicentre studyMarion Alhenc-Gelas, Luc Cabel, Frederique Berger, et al.
International Journal of Cancer|September 26, 2022
Survival outcomes of metastatic breast cancer patients by germline BRCA1/2 status in a large multicenter real-world databaseAudrey Mailliez, Veronique D'Hondt, Amelie Lusque, et al.
Therapeutic Advances in Medical Oncology|March 3, 2022
Clinicopathological characteristics and prognosis of breast cancer patients with isolated central nervous system metastases in the multicentre ESME databaseMarcela Carausu, Matthieu Carton, Luc Cabel, et al.
Oncotarget|March 9, 2018
Efficacy of histology-agnostic and molecularly-driven HER2 inhibitors for refractory cancersLuc Cabel, Alina Fuerea, Ludovic Lacroix, et al.
Frontiers in Oncology|August 29, 2022
Integrated molecular and pharmacological characterization of patient-derived xenografts from bladder and ureteral cancers identifies new potential therapiesHervé Lang, Claire Béraud, Luc Cabel, et al.
Pageof 8

Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
Breast (Edinburgh, Scotland)|February 9, 2021
Outcome beyond third-line chemotherapy for metastatic triple-negative breast cancer in the French ESME programLuc Cabel, Matthieu Carton, Barbara Pistilli, et al.
Cells|May 31, 2019
Circulating Tumor Cells and Circulating Tumor DNA Detection in Potentially Resectable Metastatic Colorectal Cancer: A Prospective Ancillary Study to the Unicancer Prodige-14 TrialFrançois-Clément Bidard, Nicolas Kiavue, Marc Ychou, et al.
Breast Cancer Research and Treatment|October 26, 2018
Oral etoposide in heavily pre-treated metastatic breast cancer: results from the ESME cohort and comparison with other chemotherapy regimensLuc Cabel, Matthieu Carton, Bianca Cheaib, et al.
NPJ Breast Cancer|January 29, 2026
Monitoring of circulating tumor DNA in patients with stage II-III breast cancer treated with neoadjuvant chemotherapyLuc Cabel, Julia Ah-Reum An, Hong-Kyu Kim, et al.
Breast (Edinburgh, Scotland)|August 9, 2022
Efficacy of taxanes rechallenge in first-line treatment of early metastatic relapse of patients with HER2-negative breast cancer previously treated with a (neo)adjuvant taxanes regimen: A multicentre retrospective observational studyAntoine Vasseur, Matthieu Carton, Severine Guiu, et al.
Breast Cancer Research : BCR|January 20, 2021
Characteristics and outcome of breast cancer-related microangiopathic haemolytic anaemia: a multicentre studyMarion Alhenc-Gelas, Luc Cabel, Frederique Berger, et al.
International Journal of Cancer|September 26, 2022
Survival outcomes of metastatic breast cancer patients by germline BRCA1/2 status in a large multicenter real-world databaseAudrey Mailliez, Veronique D'Hondt, Amelie Lusque, et al.
Therapeutic Advances in Medical Oncology|March 3, 2022
Clinicopathological characteristics and prognosis of breast cancer patients with isolated central nervous system metastases in the multicentre ESME databaseMarcela Carausu, Matthieu Carton, Luc Cabel, et al.
Oncotarget|March 9, 2018
Efficacy of histology-agnostic and molecularly-driven HER2 inhibitors for refractory cancersLuc Cabel, Alina Fuerea, Ludovic Lacroix, et al.
Frontiers in Oncology|August 29, 2022
Integrated molecular and pharmacological characterization of patient-derived xenografts from bladder and ureteral cancers identifies new potential therapiesHervé Lang, Claire Béraud, Luc Cabel, et al.
Pageof 8